PR94664

DAYTON, Ohio, Feb. 24, 2022 /PRNewswire=KYODO JBN/ --

    - Joe Newell joins board of directors as part of the company's ongoing

commitment to improving the cell and gene therapy supply chain  

CSafe Global [

https://c212.net/c/link/?t=0&l=en&o=3452919-1&h=2587996363&u=https%3A%2F%2Fcsafeglobal.com%2F&a=CSafe+Global

], the innovation leader in temperature-controlled container solutions for the

transport of life-enhancing pharmaceuticals, announced today that Joe Newell

has been appointed to the company's board of directors. With this appointment

the Board will comprise 9 directors.

Photo - https://mma.prnewswire.com/media/1752734/CSafe_Global_Joe_Newell.jpg  

Logo - https://mma.prnewswire.com/media/1501954/CSafe_Global_Logo.jpg

"We are pleased to welcome Joe to the CSafe board," said CSafe CEO and board

member, Patrick Schafer. "His vast experience from across the biopharma

industry, including his deep understanding of the cell and gene therapies

space, will be invaluable to CSafe as we grow our business in that sector and

further our mission to safely deliver life-enhancing products to patients."

"Joe is a pivotal addition to our board," said Bill Mitchell, CSafe Chairman of

the Board and Executive in Residence for Frazier Healthcare Partners.

"Expanding our portfolio to meet the unique needs of the cell and gene therapy

market has been a core strategic focus for CSafe. Joe's expert guidance in this

space will help accelerate our expansion of a truly client-centric solution."

Mr. Newell has spent his near 30-year career in the pharmaceutical and life

sciences industries. He most recently served as Chief Operations Officer for

Atara Biotherapeutics, a pioneer in allogeneic T-cell immunotherapies for

patients with serious diseases including hematologic cancers, autoimmune

disease and solid tumors. At Atara he oversaw Process Sciences, Manufacturing,

Quality, Program Management, Alliance Management, and Enterprise Services.

Prior to joining Atara, Mr. Newell held leadership roles in manufacturing,

operations, supply chain and logistics for multiple industry-leading drug

development and pharma services organizations, including Alexion

Pharmaceuticals, Amgen, Catalent Pharma Services and Cardinal Health. He holds

a bachelor's degree in Biology from California State Polytechnic University –

Pomona.

"I am extremely excited to join the CSafe Global board and work with a seasoned

and highly successful executive team," said Newell. "Csafe is a mission driven

company that leads with core values that I appreciate and a true passion for

quality and service. The company is well-positioned to deliver an unmatched,

holistic cell and gene therapy cold chain portfolio solution and distribution

network to help ensure these critical life-saving therapies can reach the

patients who need them."

Media Contact:

Lori Conaway

Global Marketing Communications

+1 405.633.2344

lconaway@csafeglobal.com

About CSafe Global

CSafe Global provides end-to-end thermal shipping solutions to the

pharmaceutical and life science industries worldwide. An industry innovator,

CSafe provides AI-enabled lease forecasting to ensure active container

availability and real-time shipment visibility for customers to monitor

shipments and intervene to preserve a payload when needed. CSafe offers

industry-leading maintenance and reuse programs for active and passive

containers providing superior product performance and alignment with customer

sustainability objectives. With a presence in 150 countries, 24/7 support and

100% container availability, CSafe is well-positioned to be the partner of

choice in the cold chain. csafeglobal.com [

https://c212.net/c/link/?t=0&l=en&o=3452919-1&h=4033319785&u=https%3A%2F%2Fcsafeglobal.com%2F&a=csafeglobal.com

]

SOURCE  CSafe Global